Neurones: 6.3% net profit in 1st half 2025

Core Viewpoint - The company reported a net profit margin of 6.3% for the first half of 2025, reflecting a challenging economic environment but still achieving growth in revenues and maintaining a stable financial position [1]. Financial Performance - Revenues for H1 2025 reached €424.3 million, an increase from €402.4 million in H1 2024, representing a growth of 5.4% [2][4]. - Business operating profit for H1 2025 was €37.4 million, with a margin of 8.8%, down from 10.1% in H1 2024 [2]. - Operating profit decreased to €33.1 million in H1 2025, with a margin of 7.8%, compared to 9.2% in H1 2024 [2]. - Net profit after tax for H1 2025 was €26.8 million, a decline from €29.2 million in H1 2024, resulting in a net profit margin of 6.3% [2][4]. - The group share of net profit was €22.7 million in H1 2025, down from €24.5 million in H1 2024 [2]. Cash Position and Staffing - Net cash, excluding financial debt, increased by €25.3 million compared to June 30, 2024, totaling €282.2 million [2][5]. - The company employed 7,264 staff at the end of H1 2025, an increase from 7,001 in H1 2024 [2]. Outlook - The company confirmed its forecasts for the full year, expecting revenues of nearly €850 million and an operating profit margin of approximately 8% [4][5].